⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CHRS News
Coherus Oncology, Inc. Common Stock
DELFI Diagnostics Appoints Charles Newton to Board of Directors
prnewswire.com
NVAX
CHRS
Oncology Clinical Trials Research Report 2026: $20+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
PFE
JNJ
MRK
ABBV
NVS
CHRS
Throat Cancer Market Trends and Breakthroughs Through 2026-2030 & 2035 Driven by Precision Oncology
globenewswire.com
PFE
MRK
ABBV
INO
CHRS
Tumor Microenvironment Market to Reach Over $2.7 Billion by 2030 - Rising Demand for Personalized Oncology Therapies and Next-Gen Immunotherapies Driving the Industry
globenewswire.com
PFE
JNJ
MRK
ABBV
CHRS
Head and Neck Cancer Market to Expand at 7.8% CAGR During 2026-2030 as Immuno-Oncology Therapies Offer Promising Advances in HNC Treatments
globenewswire.com
PFE
MRK
AZN
CHRS
Paranasal Sinus Cancer Markets and Competition Outlook 2026-2030 - Precision Oncology, Minimally Invasive Surgeries, and Expanded Cancer Care Models Drive Revenue Growth
globenewswire.com
BMY
CHRS
Loqtorzi (toripalimab-tpzi: Inovio Pharmaceuticals, Coherus BioSciences) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
INO
CHRS
Form 8-K
sec.gov
CHRS
Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
CHRS
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026
globenewswire.com
CHRS